ClinConnect ClinConnect Logo
Search / Trial NCT00877344

Better Contraceptive Choices: Immediate or Delayed Insertion of IUC After Second Trimester Abortion

Launched by UNIVERSITY OF BRITISH COLUMBIA · Apr 6, 2009

Trial Information

Current as of May 04, 2025

Unknown status

Keywords

Pregnancy Iuc Abortion Contraception

ClinConnect Summary

This Randomized Controlled Trial will be offered to women choosing to have a LNG-IUC or CuT380 after an abortion for gestational ages from 12 to 24 weeks. \[delete next insert\]"and a non intervention control group offered to all others having abortions at this gestational age". Participants choosing an LNG-IUC or CUT380 will be randomly assigned to immediate or interval insertion. In conjunction with follow up visits and questionnaires, the British Columbia Linked Health Database access will determine pregnancy rate within one year for the two intervention groups \[delete next insert\] and...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Have completed informed consent for an abortion at gestation between 12 weeks zero days and 23 weeks 6 days, and
  • 2. Choosing an IUC (either LNG-IUC or CuT380-IUC) for contraception post abortion, and
  • 3. Residents of British Columbia, registered with the Medical Services Plan health care system.
  • Exclusion Criteria:
  • 1. Intention to move from BC within the next year
  • 2. Intention to conceive within the next year.
  • 3. Any of the following contraindications to use of a LNG-IUC or a CuT380-IUC
  • 4. Post Randomization Exclusion:
  • uterine perforation at the time of abortion
  • bleeding of more than 500 cc during abortion
  • any of the above exclusions detected at time of abortion

About University Of British Columbia

The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.

Locations

Vancouver, British Columbia, Canada

Kelowna, British Columbia, Canada

Vancouver, British Columbia, Canada

Patients applied

0 patients applied

Trial Officials

Wendy V. Norman, Ph.D

Principal Investigator

University of British Columbia

Brian Fitzsimmons, MD

Study Director

University of British Columbia

Lyda Dicus

Study Chair

University of British Columbia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials